Cardio Diagnostics Holdings, Inc. (CDIO)
NASDAQ: CDIO · Real-Time Price · USD
2.030
0.00 (0.00%)
At close: Apr 8, 2026, 4:00 PM EDT
2.100
+0.070 (3.45%)
After-hours: Apr 8, 2026, 7:07 PM EDT
CDIO Market Cap
CDIO has a market cap or net worth of $6.01 million as of April 8, 2026. Its market cap has decreased by -74.40% in one year.
Market Cap
6.01M
Enterprise Value
1.59M
1-Year Change
-74.40%
Ranking
Category
Stock Price
$2.03
Market Cap Chart
Since July 26, 2022, CDIO's market cap has decreased from $368.96M to $6.01M, a decrease of -98.37%. That is a compound annual growth rate of -67.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 6.01M | 21.40% |
| Dec 31, 2025 | 4.95M | -86.66% |
| Dec 31, 2024 | 37.08M | -27.41% |
| Dec 29, 2023 | 51.09M | 406.54% |
| Dec 30, 2022 | 10.09M | -97.27% |
| Jul 26, 2022 | 368.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioRestorative Therapies | 6.34M |
| Ernexa Therapeutics | 6.25M |
| Addex Therapeutics | 6.25M |
| MetaVia | 6.13M |
| XTL Biopharmaceuticals | 6.01M |
| Purple Biotech | 5.90M |
| Mustang Bio | 5.74M |
| Psyence Biomedical | 5.68M |